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Bacterial exopolysaccharides (EPSs) are biomolecules secreted in the extracellular space and have diverse biological functionalities,
such as environmental protection, surface adherence, and cellular interactions. EPSs have been found to be biocompatible and
eco-friendly, therefore making them suitable for applications in many areas of study and various industrial products. Recently,
synthesis and stabilization of metal nanoparticles have been of interest because their usefulness for many biomedical
applications, such as antimicrobials, anticancer drugs, antioxidants, drug delivery systems, chemical sensors, contrast agents,
and as catalysts. In this context, bacterial EPSs have been explored as agents to aid in a greener production of a myriad of metal
nanoparticles, since they have the ability to reduce metal ions to form nanoparticles and stabilize them acting as capping agents.
In addition, by incorporating EPS to the metal nanoparticles, the EPS confers them biocompatibility. Thus, the present review
describes the main bacterial EPS utilized in the synthesis and stabilization of metal nanoparticles, the mechanisms involved in
this process, and the different applications of these nanoparticles, emphasizing in their biomedical applications.
1. Generalities of Exopolisaccharides (EPSs)
Microbial exopolysaccharides (EPSs) are biopolymers pro-
duced and secreted by microbial cells to the extracellular
medium, forming a capsule or slime loosely attached to the
cell surface [1]. These compounds can be soluble or insoluble
polymers released into the surrounding environment to
accumulate outside the cells [2, 3]. Thus, they can be encoun-
tered attached to the microbial cell surface or within the
fermentation medium [2]. Synthesis of EPSs is important to
microbial cells since EPSs play crucial biological roles in their
survival. Among these functions include cell protection,
attachment to solid surfaces, cell aggregation, and cell-cell
interactions [4, 5]. There are various groups of microorgan-
isms that can produce EPS; bacteria (including extreme and
marine bacteria) [4–6], cyanobacteria [6], fungi and yeasts
[7], and microalgae [8]. Some of the most studied EPSs
produced by microorganisms are xanthan, dextran, alginate,
gellan, levan, cellulose, curdlan, pullulan, succinoglycan, and
hyaluronic acid [9–11]. In this context, based on their
functionality, EPSs have been classified in the following cate-
gories: constructive or structural, sorptive, surface active,
informative, redox active, and nutritive [12]. Moreover, EPSs
from extreme bacteria possess unique and specific properties
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of interest since metabolic products from these types of
bacteria have evolved to adapt to extreme environmental
conditions [6].
The structure of EPSs is mainly conformed of
carbohydrates such as monomers of D-glucose, D-galactose,
D-mannose, L-fucose, L-rhamnose, D-glucuronic acid, D-
galacturonic acid, L-guluronic acid, D-mannuronic acid,
N-acetyl-D-glucosamine, and N-acetyl-D-galactosamine,
as well as noncarbohydrate components that confers an
anionic nature to the EPSs such as carboxyl, phosphate,
sulfate, and pyruvate substituents [10, 13–16]. In addition
of the negative charge, these organic groups increase the
lipophilicity of the EPSs and have influence in the interaction
with other polysaccharides and cations [10]. The structure of
some microbial EPSs is shown in Figure 1.
2. Main Bacterial EPSs
Xanthan gum is a heteropolysaccharide EPS produced by the
genus Xanthomonas and is the first natural biopolymer
produced at an industrial scale [10, 17]. Dextran is a
homopolysaccharide composed of α-glucans and produced
by the Leuconostoc, Streptococcus, and Lactobacillus genera
[10, 18]. Curdlan is a nonbranching linear polysaccharide
composed of β-glucan and produced by Alcaligenes faeca-
lis [19]. Gellan gum is a sphingan heteropolysaccharide
synthesized by the genera Sphingomonas and is composed
of acetyl and glyceryl substituents [20]. Cellulose is another
β-glucan that can be produced by the genera Gluconaceto-
bacter, Agrobacterium, Aerobacter, Achromobacter, Azoto-
bacter, Rhizobium, Sarcina, and Salmonella [21]. Levan is a
homopolyfructose-branched EPS produced by microorgan-
isms from the genera Zymomonas, Pseudomonas,Mycobacte-
rium, Corynebacterium, Erwinia, Bacillus, and Azotobacter
[22, 23]. Succinoglycan is a biopolymer composed of one
galactose and seven glucose residues with succinyl, acetyl,
and pyruvyl as nonsaccharide substituents; this EPS has been
found to be produced by some genera such as Rhizobium,
Alcaligenes, Pseudomonas, and Agrobacterium [10, 24].
Other more recent bacterial EPSs that have been reported
are FucoPol, a heteropolysaccharide produced by Entero-
bacter A47, which is composed of fucose, galactose,
glucose, and glucoronic acid with the nonsaccharide substit-
uents pyruvate, succinate, and acetate [25] and GalactoPol,
a polysaccharide produced by Pseudomonas oleovorans
aNRRL B-14682 mainly formed by galactose and other
saccharides as glucose, mannose, and rhamnose in lower
amounts [26]. Both of these EPSs are obtained by their
respective bacteria using glycerol as sole carbon source.
The information of this section is summarized in Table 1.
3. Application of EPSs
Many areas such as chemistry, food, cosmetics, hydrocol-
loids, pharmaceuticals, medicine, packaging industries,
textiles, detergents, adhesives, agriculture, wastewater treat-
ment, and nanotechnology have benefited from the use of
EPS [2, 10, 27]. These industrial areas have taken advantage
of the properties of EPS to elaborate many different products;
such as adhesives, absorbents, lubricants, rheology modi-
fiers, viscosifiers, emulsifiers, chelating agents, biomaterials
intended to serve as drug delivery vehicles encapsulating
bioactive biomolecules, anticancer agents, imaging, tissue
engineering, antimicrobial agents, and as a reducting
and stabilizer agent in the synthesis of metal nanoparticles
[2, 6, 28–32]. Moreover, EPS have been reported to be gener-
ally recognized as safe (GRAS) compounds, meaning that
they do not represent a health risk in their use [33]. Due to
these properties, other applications of EPS are currently
being explored, among them are sorption, their use in the
removal of toxic metals and carbon dioxide [34, 35], improv-
ing activated sludge settleability [36], and designing aqueous
foams with clay nanoparticles to avoid the emission of
volatile organic compounds during oil or gasoline loading
and storage [37]. In regard to this, EPS frommarine microor-
ganism have also been found to have interesting properties
such as good antioxidant activity [38, 39], blocking effect to
avoid the adherence of gastrointestinal pathogens, anticancer
and antiviral effect in human cell lines [40–42], restoration of
bone integrity, and anticoagulant properties [43]. Thus, as
described in this section, EPSs offer a wide range of applica-
tions. In this review, we focus on the ability of bacterial EPSs
to act as reducing and stabilizing agents during the synthesis
of metallic nanoparticles for applications in biology and the
medical field.
3.1. EPS Used in the Synthesis of Metal Nanoparticles. Metal
nanoparticles have been the target of research within the last
two decades, since they have been found to have different and
enhanced properties when compared to those exhibited by
the bulk metals [44]. These nanoparticles also present high
reactivity due to their crystallographic surface structure and
large surface area [45]. All of these properties allow for
metallic nanoparticles to be applied in areas such as
medicine, electronics, environment, agriculture, health care,
and pharmaceutical products.
There are physical, chemical, and biological methods to
produce and synthesize metal nanoparticles. Biological
methods or green synthesis mainly use plant extracts. Fungal
and bacterial strains and their cultures have been explored
recently since they provide an environmentally friendly and
cost-effective synthesis platform that employs nontoxic
reagents and procedures [46]. Green synthesis has been used
to elaborate many different metal nanomaterials such as Ag,
Au, Zn, Ti, TiO2 Ni FeO, Fe3O4, Cu, Co, Pd, Ba, CdS, and Pt
nanoparticles [47–51]. Thus, much emphasis has been placed
in the discovery of effective reducing and stabilizing agents to
synthesize metallic nanoparticles. In this context, EPSs
contain various functional groups in their structure that can
serve as reductive and stabilizing agents in the synthesis of
metal nanoparticles by a chelating and capping process
[52]. These processes allow control on size, shape, and
particle dispersion [33]. Further, during synthesis of metal
nanoparticles in the presence of EPSs, their mucoadhesion
properties lead to a neutral, low surface energy and low level
of nonspecific protein receptor recognition capping, making
these nanoparticles more adequate to utilize in broader appli-
cations [33]. A general representation of possible interactions
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between EPS and metal ions to form metal nanoparticles is
shown in Figure 2.
In this context, it is important to mention that in most
cases in which EPSs are utilized to synthesized metal nano-
particles, the EPSs act both as a reducing and stabilizing
agents at the same time due to their properties and structures
with many functional groups; which consequently make
EPSs suitable and advantageous to produce metal nano-
particles destined to be applied in the biomedical sciences
[53–57]. However, there are also studies in which metal
nanoparticles are produced with other reducing agents or
other reducing methods, where the EPSs act only as a
stabilizing or capping agent [58–60].
3.2. Differences between Polysaccharides and
Exopolysaccharides in the Preparation of Metal Nanoparticles.
There are differences between commercial polysaccha-
rides and extracted microbial exopolysaccharides, mainly
regarding their composition. As mentioned previously,
polysaccharides are mainly composed by carbohydrates.
Cellulose, as well as starch, is composed by D-glucose;
alginate is composed by β-D-mannuronate and α-L-
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Figure 1: Structure of somemicrobial exopolysaccharides. The chemical structure of diverse microbial EPSs can differ in functional groups or
sugars branched in the main chain structure. (a) Hyaluronic acid, (b) curdlan, (c) xanthan, (d) dextran, and (e) gellan. The “n” indicates the
polymerization degree of the polysaccharides, and it can vary significantly from bacteria strain and culture conditions.
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guluronate; carboxymethyl cellulose is a polymer of D-
glucose with carboxymethyl groups bonded to the
hydroxyl groups; pectin is mainly composed by galac-
turonic acid, linked to other components as acetic acid,
D-apiose, glucorinic acid, etc. Polysaccharides have many
functionalities, which include the capability of their
hydroxyl groups and hemiacetal ends to reduce metal
precursor salts [61]. Metallic nanoparticles synthesized with
polysaccharides are often reduced in alkaline conditions
to achieve better pH conditions for the synthesis or to
hydrolyze the polysaccharide to increase the amount of
available reducing sugars [62, 63].
On the other hand, exopolysaccharides, besides being
composed primarily of carbohydrates, may have organic and
inorganic substituents, as shown in Table 2 [64]. Some EPS
of cyanobacteria are mostly heteropolysaccharides, containing
S functional groups linked to the sugar backbone [65].
Similarly, there are reports of carbohydrate backbones
containing S in their chemical composition in the EPS of some
Bacillus strains [66, 67]. There are some N-acetylamino sugars
that have been not found in commercial microbial polysaccha-
rides [64]. The introduction of these amino functionality in
the reducing end of EPS make them capable of complexing
and stabilizing much better metallic nanoparticles [68].
4. Role of Bacterial EPSs in the Synthesis of
Metallic Au and Ag Nanoparticles with
Biomedical and Other Applications
Among the most studied and broadly produced nanoparti-
cles, through green synthesis methods, are silver (Ag-NPs)
Table 1: Main bacterial EPS and the bacteria that produce them.
Exopolysaccharide Bacteria Reference
Xanthan gum Xanthomonas [10, 17]
Dextran Leuconostoc, Streptococcus, and Lactobacillus [10, 18]
Curdlan Alcaligenes faecalis [19]
Gellan gum Sphingomonas [20]
Cellulose
Gluconacetobacter, Agrobacterium, Aerobacter, Achromobacter, Azotobacter,
Rhizobium, Sarcina, and Salmonella
[21]
Levan Zymomonas, Pseudomonas, Mycobacterium, Corynebacterium, Erwinia, Bacillus, and Azotobacter [22, 23]
Succinoglycan Rhizobium, Alcaligenes, Pseudomonas, and Agrobacterium [10, 24]
FucoPol Enterobacter A47 [25]
GalactoPol Pseudomonas oleovorans aNRRL B-14682 [26]
M2- M2-
M2-
M2-
M2-
M2-
M2-
M2-
M2-
M2-
M2-
M2-
M2-
M2-
M2-
M2-
M
M
Figure 2: General representation of EPSs as a reducing and stabilizer agent to produce metal nanoparticles. Metal ions can be coordinated by
the functional groups of the exopolysaccharide. Then, the metal can be reduced either by the exopolysaccharide or a different reducing agent.
Once the nuclei was formed, it can grow stabilized by the microbial exopolysaccharide.
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and gold (Au-NPs) nanoparticles. Many of these studies
report the use of EPS as reducing and stabilizing agents
during their synthesis. For instance, xanthan gum has been
used in the synthesis of Au-NPs and these EPSs proved to
be an effective drug delivery carrier for doxorubicin
hydrochloride to human lung cancer cells [69]. Furthermore,
xanthan gum EPSs have been shown to aid in the synthe-
sis of Ag-NPs with enhanced catalytic properties and
antibacterial activity against Escherichia coli and Staphylo-
cocus aureus [70].
Dextran is a well-known EPS used to produce Ag-NPs
with applications as chemical sensors for cysteine [71].
Moreover, Ag-NPs with antibacterial and antifungal proper-
ties have also been synthesized using dextran sulfate [72]. For
the case of Au-NPs, these particles have been obtained using
dextran as a capping and reducing agent [55]. In this
study, the Au-NPs showed antitumor effects against Ehr-
lich ascites carcinoma and solid carcinoma transplanted
in mice through tests performed to evaluate liver and kidney
biochemical function, as well as oxidation stress ratio and
histopathological studies.
Curdlan and other modified compounds of EPSs have
been useful to produce Ag-NPs using 4-acetamido-2,2,6,6-
tetramethypiperidine-1-oxyl radical- (TEMPO-) oxidized
curdlan [73], and also, nontoxic and biocompatible Au-NPs
were produced using carboxylic curdlan. For the last study,
the interaction of Au-NPs with bovine serum albumin were
tested, indicating that these nanoparticles do not produce
significant changes in protein structure [74].
Sphingans, such as gellan, have been used as reducing
and stabilizing agents to elaborate Au-NPs for drug delivery
formulations with cytotoxic effects against human glioma cell
lines LN-18 and LN-229 [75]. Using gellan gum, a highly sta-
ble water dispersion of antibacterial Ag-NPs was synthesized
and tested their cytotoxicity in mouse embryonic fibroblast
cells (NIH3T3), as well as their diffusion across rat skin
[76]. Finally, Au-NPs were produced with the same EPS
revealing that these nanoparticles are uptaken by the human
glioma cell line LN-229 and do not possess toxicity after oral
administration in rats [77].
For the case of cellulose, previous works have stated that
microbial cellulose in comparison to plant cellulose can be
extracted with greater purity and a higher level of polymeri-
zation and crystallinity [78]. Bacterial cellulose has been
employed as a stabilizing agent of metallic nanoparticles,
such is the case of Ag-NPs that coat the surface of bacterial
cellulose nanofibers [79]. Ag-NPs stabilized by microbial
cellulose have also been synthesized to be used as optical
sensors of cyanide ions and 2-mercaptobenzothiazole in
water samples [80]. Bacterial cellulose nanofibers have been
shown to act as templates for synthesis of Au-NPs to produce
nanocomposites formed by Au-NPs nanofibers in aqueous
suspension. These nanocomposites have been used to immo-
bilize the horseradish peroxidase enzyme tomake a biosensor
to detect H2O2 [81].
Levan is another microbial EPS, obtained from Acetobac-
ter xylinum NCIM 2526, that has been used for the synthesis
of Ag-NPs and Au-NPs with catalytic activity, tested by
reduction of 4-nitrophenol and methylene blue [82]. In this
study, levan acted as an additional reducing and stabilizer
agent during thermal reduction method and as stabilizer or
capping during chemical reduction method.
Succinoglycan (sinorhizobial octasaccharide) isolated
form Sinorhizobium meliloti is an EPS used to stabilize Ag-
NPs [83]. The presence of this EPS has been shown to confer
biocompatible characteristics to the nanoparticles [84]. In
addition, it is important to note other novel EPSs extracted
from bacteria that have been useful in the synthesis of Ag-
NPs and Au-NPs. EPS from Lactobacillus rhamnosus has
been reported to be used in the synthesis of Ag-NPs with
antimicrobial activity against bacterial (Pseudomonas aerugi-
nosa, Klebsiella pneumonia, and Listeria monocytogenes) and
fungal pathogens (Aspergillus and Penicillium spp.) [33].
Ag-NPs with antibacterial and antibiofilm activity against
gram (+) and gram (−) bacteria were produced using an
EPS extracted from Lactobacillus brevisNM101-1 [85]. These
Ag-NPs were effective as antibiotic adjuvants to enhance
their antimicrobial activity. EPS from Lactobacillus plan-
tarum was utilized in the production of Au-NPs to design a
drug delivery agent against multidrug-resistant bacteria.
The design involved the use of antibiotics to functionalize
the Au-NPs to improve their antimicrobial properties [86].
An additional strain of Lactobacillus plantarum-605 was
used to produce nonglucan EPS-605 useful for the synthesis
of Ag-NPs and Au-NPs [87]. Antibacterial Ag-NPs have
been synthesized in the presence of EPSs from Lactobacillus
casei (LPW2E) and Lactobacillus fermentum (LPF6) [88].
Moreover, Ag-NPs with applications in the degradation of
azo dyes have been synthesized using EPS produced by
Leuconostoc lactis KC117496 EPS [89].
The genera Bacillus has also been found to produce EPSs
with applications in the synthesis of metal nanoparticles. A
bioflocculant EPS from marine Bacillus subtilis MSBN17
was used to elaborate Ag-NPs tested as an antibacterial agent
in sewage water and also as an antibiotic enhancer against
pathogenic microorganisms when combined [90]. Au-NPs
with antibacterial activity against clinical pathogenic bacteria
Table 2: Different noncarbohydrate substituents found in microbial
exopolysaccharides.
Substituent Appearance in microbial EPS
Organic acids
Acetate Very common
Glycerate Pseudomonas elodea
Hydroxybutanoate Rhizobium irifolii
Propionate Escherichia coli
Pyruvate Very common
Succinate Rhizobium spp., Agrobacterium spp,
Amino acids
L-glutamate Klebsiella
Serine E. coli
Inorganic acids
Phosphate Common
Sulfate Cyanobacteria, Bacillus spp.
5International Journal of Polymer Science
were produced using EPS from marine Bacillus megaterium
MSBN04 [91]. Additionally, Ag-NPs were produced on the
basis of low and high molar mass of EPS obtained from
diazotrophic Bradyrhizobium japonicum 36 strain. In this
study, the nanoparticles were synthetized using low molecu-
lar mass EPS and had antibacterial and antifungal activities
against Escherichia coli, Staphylococcus aureus, and Candida
albicans [92].
To summarize this section, the silver and gold nanoparti-
cles as well as their uses in which EPSs have been used as a
reducing and/or stabilizing agent to synthesize them are
showed in Table 3.
5. Role of Bacterial EPSs in the Synthesis of
Other Metal Nanoparticles with Biomedical
and Other Applications
EPSs have also been used in the synthesis of other metal
nanoparticles, such is the case of xanthan gum, that has been
used as a reducing and stabilizing agent to produce palladium
nanoparticles (Pd-NPs) with very good catalytic activity
during the reduction of 4-nitrophenol to 4-aminophenol by
sodium borohydride [93]. Xanthan gum has also been used
to stabilize Pd/Fe-NPs employed to remediate polychlori-
nated biphenyl- (PCB-) contaminated soil in combination
with surfactant BriJ35 by means of electrokinetic nanoparti-
cle method, showing an enhancing of the degradation of
PCB28 [94].
Dextran has been used to produce iron oxide nanoparti-
cles. Indeed, this EPS was used to coat magnetic nanoparti-
cles to produce biocompatible ferrofluids using the
coprecipitation method. In this study, the dextran-coated
iron oxide nanoparticles presented significant less cytotoxic-
ity to L929 cells in comparison to the same bare nanoparticles
making them more suitable for diagnostic and therapeutic
purposes [95]. Likewise, dextran was used as a stabilizing
agent of iron oxide magnetic nanoparticles which were
evaluated on in vitro and in vivo toxicological assays, showing
them as nontoxic and safe nanoparticles to be used for
biomedical applications [96].
Furthermore, carboxylic curdlan (Cur-4, Cur-8, and Cur-
24) offers reducing and stabilizing agent properties in the
production of selenium nanoparticles (Se-NPs) [57]. These
nanoparticles presented a strong antioxidant capacity and
low cytotoxic activity against SPCA-1 and HeLa cell lines
in vitro. Similarly, zinc oxide nanoparticles (ZnO-NPs) were
obtained by carboxylic curdlan, evaluating the interaction of
these nanoparticles with bovine serum albumin showing
mild modification of its conformation [60].
Interestingly, with a combination of alginate and gellan
(50 : 50 solution), Pd-NPs were stabilized and used as a
catalyst system [58]. In this study, the EPSs combination
were carried out looking for improvement of the catalytic
function of alginate/gellan-stabilized Pd-NPs taking advan-
tage of synergistic interactions among EPSs [58, 97, 98],
showing that combining the appropriately different EPSs
may be useful in the synthesis, stabilization, and improving
properties of metal nanoparticles. In this context, magnetic
nanoparticles tested as drug carrier system of the anticancer
drug 2,4-dihydroxy-5-fluoruracil (5FU) against the cancer
cells MCF7, G1, and L929 were stabilized and coated using
gellan gum and mauran [59].
Cellulose has also been employed to make other metal
nanoparticles such as cadmium sulfide (CdS-NPs). These
particles were produced by means of bacterial cellulose
nanofibers and were proposed to be used as photocatalyst,
luminescence, and photoelectron transfer devices [99].
Evenly, antibacterial nanocomposites formed of bacterial
cellulose-cooper oxide nanoparticles were obtained by
hydrothermal deposition [53].
Levan has been used to produce and coat cerium oxide
nanoparticles as both reducing and stabilizing agents. These
nanoparticles were suggested to have applications to treat
diseases related to oxidative stress, due to their antioxidant
activity tested in H2O2-stimulated NIH3T3 cells [54]. The
above nanoparticles resulted nontoxic and biocompatible in
cytotoxic studies with mouse fibroblast NIH3T3 cells and
HEK293T cells. Likewise, levan was applied to coat and stabi-
lize biocompatible Se, Fe, and Co nanoparticles as a strategy
to obtain better food supplements with micronutrients safer
and more efficient for humans [100].
In addition, recent EPSs such as FucoPol have been used
to coat functionalized iron oxide magnetic nanoparticles. For
instance, these nanoparticles functionalized with synthetic
ligand applied for purification and recovery of antibodies
were coated with FucoPol [101]. In another study, nanop-
robes of the same nanoparticles, in this case, functionalized
with meso-2,3-dimercaptosuccinic acid (DMSA), were also
coated with the same EPS and tested for cell labeling in mag-
netic resonance imaging (MRI) [56].
It is important to that note other bacterial EPSs have been
used as reducing and stabilizing agents such is the case of
EPSs obtained from Bacillus licheniformis Dahb1 used to
synthetize ZnO nanoparticles by the coprecipitation method
[102]. These nanoparticles presented effective antibacterial
and antibiofilm activity against both gram negative and gram
positive bacteria, as well as antifungal and larvicidal activity
with low cytotoxicity in hemolytic assays. In addition, mag-
netic iron oxide nanoparticles were produced and stabilized
by a spore-forming strain of Bacillus subtilis EPS [103]. The
nanoparticles mentioned presented antibacterial activity,
high bioavailability, and cytotoxicity against human epider-
moid carcinoma cell line (A431).
To summarize this section, other metal nanoparticles as
well as their uses in which EPSs have been used as a reducing
and/or stabilizing agent to synthesize them are shown in
Table 3.
6. Potential Mechanisms That Explain the
Synthesis of Metal Nanoparticles by
Bacterial EPSs
In general, it has been noted that once metal ions are in
contact with EPSs that contain reducing sugars, they are
chelated and then reduced and stabilized by various
functional groups. Polyanionic groups are the best known
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Table 3: Characteristics of metallic nanoparticles synthesized by means of bacterial exopolysaccharides.
Bacterial EPS
Metallic
nanoparticle
Mean size
(nm)
Morphology Applications Reference
Xanthan gum
Au-NPs 15–20 Spherical
Drug delivery carrier,
anticancer therapy
[69]
Ag-NPs 5–40 Spherical Antibacterial and catalytic [70]
Pd-NPs 10 Spherical Catalytic [93]
Pd/Fe-NPs 10–20 Spherical Soil remediation [94]
Dextran
Ag-NPs 12± 1.9 Nearly spherical Sensor for cysteine detection [71]
Ag-NPs 10–60 Spherical Antibacterial and antifungal [72]
Au-NPs 13± 1.2 Spherical Anticancer [55]
Fe3O4-NPs 14, 10.7 Spherical Biocompatibility [95]
Fe3O4-NPs 15.4± 4.5 Spherical Toxicological assays [96]
Curdlan
Ag-NPs 15 Spherical Not tested [73]
Au-NPs 17, 24 Spherical Interaction with proteins [74]
Se-NPs 82, 56, 65 Spherical Antioxidant, cytotoxicity assays [57]
Zn-NPs 58± 6 nm Spherical Protein interaction [60]
Gellan gum
Au-NPs 13± 1 Spherical Drug delivery carrier,
anticancer therapy
[75]
Au-NPs 14 Spherical
Drug delivery carrier,
anticancer therapy
[77]
Ag-NPs 5 Spherical Antibacterial and topical treatment [76]
∗Pd-NPs 3.4± 1.4 Spheroidal Catalytic [58]
Fe3O4-NPs 15± 3 Spherical Drug delivery carrier, anticancer [59]
Cellulose
Ag-NPs 13.1 Not available Nanofibers [79]
Ag-NPs 10–50 Not available Chemical sensor [80]
Au-NPs 9 Nearly spherical
Enzyme immobilization
and biosensing
[81]
CdS-NPs 30 Spherical Nanofibers, thermal stability [99]
Cu-NPs 25, 35 Not available Antibacterial, nanofibers [53]
Levan
Ag-NPs and Au-NPs
5–29 and
10–30
Spherical Catalytic [82]
Ce oxide-NPs 36.4± 9.2 Spherical Antioxidant, biocompatibility [54]
Co3O4-NPs 9.9± 2.3
Spherical
Prebiotic and micronutrients
supplements
[100]Fe3O4-NPs 10.6± 3.4
Se-NPs 60± 26
Succinoglycan
Ag-NPs 13.3± 13.4 Spherical Not tested [83]
Ag-NPs 8.9± 3.3 Spherical Not tested [84]
FucoPol
Fe3O4-NPs 10–20 Not available
Purification and recovery
of antibodies
[101]
Iron oxide magnetic-
NPs
15± 2 Not available Contrast agents for MRI [56]
Lactobacillus
rhamnosus EPS
Ag-NPs 10
Spherical, triangular,
rod, and hexagonal
Antibacterial and antifungal [33]
Lactobacillus brevis
NM101-1 EPS
Ag-NPs 18 Spherical Antibacterial, antibiotic adjuvant [85]
Lactobacillus
plantarum EPS
Au-NPs 20–30
Spherical, little
ellipsoidal
Drug delivery carrier,
antibacterial, and antibiotic
functionalization
[86]
Lactobacillus
plantarum-605 EPS-605
Au-NPs and
Ag-NPs
12 and 20 Spherical Not tested [87]
Lactobacillus casei EPS Ag-NPs 0.2–10
Rectangular,
spherical
Antibacterial [88]
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chemical moieties to be involved in the reduction and stabi-
lization of metal nanoparticles [27]. Moreover, electrostatic
interactions between metal cationic ions and anionic groups
such as carboxylic and phosphoric functional groups of EPS
have been mentioned to be an advantage for the synthesis
of metal nanoparticles [29]. Among these functional groups,
hydroxyl, carboxyl, phosphoric, hemiacetal, and amino end
groups have been proposed to reduce metal ions from
the precursor salts to obtain the respective nanoparticles
[52, 68, 104]. In relation with the above, hydroxyl groups
have been attributed the ability to coordinate with metal
ions [105]. In fact, during the reducing process, oxidation
of hydroxyl groups to form carbonyl groups as well as
oxidation of alcoholic and aldehydic groups to form carbox-
ylic groups has been reported to be an important factor
during synthesis of metal nanoparticles [106]. In regard with
this, reaction conditions such as temperature, time of
reaction, concentration of reactants, and pH have an influ-
ence in the morphological characteristics and mechanisms
of producing nanoparticles [92, 103]. Once the nanoparticles
are made, the EPS matrix forms a film or layer that acts as a
capping and stabilizer, thereby obtaining metal nanoparticles
with a small and tight size distribution, preventing agglomer-
ation [52, 107]. These processes can be explained by the
adsorption of the EPSs in the nanoparticle surface, promot-
ing steric repulsion between them and augmenting the
viscosity of the complex nanoparticles-EPS impeding their
aggregation [69]. In this context, it is noteworthy to mention
that capping agents affect characteristics of metal nanoparti-
cles such as surface charge and colloidal stability [108].
Thus, in relation to the EPSs described in this study, the
structure of xanthan gum has been described to be helical
with many hydroxyl groups that can carry out reduction of
ions. In addition, this structure creates a network by hydro-
gen bonding in which nanoparticles stabilize [70]. Further,
xanthan gum has negative charge due to acetyl groups and
pyruvic acid linked with mannose and provides this charge
to nanoparticle surface creating a steric repulsion among
them [69]. Dextran, is useful in the synthesis of metal
nanoparticles since their hydroxyl, ketone, aldehydes, and
carboxyl groups interact and allow the reduction of Ag+
ions to form Ag-NPs, preventing their agglomeration as
well [71, 72]. At this point, it was mentioned that oxygen
from dextran functional groups can donate their pair of
electrons to gold ions thereby producing Au-NPs [55]. As it
is well known, dextran is rich in hydroxyl groups that can
interact with magnetic nanoparticles by hydrogen bonds
stabilizing them [95, 109].
For curdlan, the carboxylic groups of curdlan derivatives
such as carboxylic curdlan and carboxymethyl curdlan have
the ability to adsorb metal ions by electrostatic attractive
forces. These functional groups reduce the metal ions, and
the necessary nucleation is created to form stabilized
clusters during synthesis of Au-NPs, Ag-NPs, and ZnO-
NP, as well as stabilization of Se-NPs [57, 60, 73, 74]. In
this context, it is noteworthy to mention that curdlan is
not soluble in water; therefore, it is carboxymethylated,
oxidized, and its sodium salt is formed, in order to improve
their properties [110].
Moreover, for the case of gellan gum, this anionic EPS
envelope itself, which has been attributed to the stabilization
of nanoparticles, and also it has abundant carbohydrate units
that form the capping of Au-NPs [75, 77]. Similar to others
bacterial EPSs, gellam gum has acyl groups and abundant
carboxyl groups that may interact with metal ions to reduce
and stabilize the respective nanoparticles [59].
Oxidizing bacterial cellulose by TEMPO allows the
introduction of carboxylate groups that carry out ion-
exchange reactions with metal ions to reduce them and
synthesize metal nanoparticles [79, 111]. These EPSs have
been utilized in nanofibers which are responsible of reduc-
tion and adsorption of metal as Ag+ and Cd+2 to form
nanoparticles by hydroxyl groups, as well as attracting
other metal nanoparticles like Au-NPs due to electrostatic
Table 3: Continued.
Bacterial EPS
Metallic
nanoparticle
Mean size
(nm)
Morphology Applications Reference
Lactobacillus
fermentum EPS
Ag-NPs 0.0–10
Rectangular,
spherical
Antibacterial [88]
Leuconostoc
lactis KC117496
Ag-NPs 35 Spherical Biodegradation agent [89]
Bacillus subtilis
MSBN17 EPS
Ag-NPs 60 Spherical
Antibacterial,
antibiotic adjuvant
[90]
Bacillus megaterium
MSBN04 EPS
Au-NPs 10 Spherical
Seawater treatment
antibacterial
[91]
Bradyrhizobium
japonicum 36 EPS
Ag-NPs 5–50 Rod, oval Antibacterial, antifungal [92]
Bacillus licheniformis
Dahb1 EPS
ZnO-NPs 100 Hexagonal
Antibacterial, antifungal,
antioxidant, and larvicidal
[102]
Bacillus subtilis,
VT03 EPS
FeO-NPs 106± 12 Spherical Antibacterial, anticancer [103]
∗Nanoparticles produced by 50 : 50 solution of alginate/gellan mixture.
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repulsion [80, 81, 99, 112]. The hydroxyl groups have
been described to be abundant in cellulose nanofibers
and very important factor to explain physical properties of
cellulose [113, 114].
In the case of levan, it has a lot of keto sugar units, and
similar to other bacterial EPSs, it has numerous hydroxyl
functional groups that may interact electrostatically with ions
such as Ag+ leading to the formation of the respective
nanoparticles [82]. In this context, succinoglycan has been
proposed to act as a reducing and stabilizing agent also
due to hydroxyl groups that may give an electron to Ag+
to form Ag and is also capable to be involved in the
formation of a complex matrix that carries out the stabili-
zation acting as a capping agent [84]. FucoPol has been
used as a capping agent for magnetic nanoparticles being
described to have a negative character because of its
substituents that exhibit suitable stabilizing properties due
to its good flocculation and emulsification process [115].
During stabilizing function of FucoPol, it has been men-
tion that this effect is dependent of steric and electrostatic
interactions [56].
Additionally, related to similar mechanisms involved
during synthesis and stabilization of metal nanoparticles
reported with other EPSs, it has been described abundant
functional groups as hydroxyl and hemiacetal ends in EPSs
that carried out the reduction and stabilization of nanoparti-
cles making them more suitable for application in different
fields of study [86, 89]. Actually, sugar monomers like glu-
cose, galactose, mannose, and fructose have been mentioned
to reduce Ag+ ions to produce Ag-NPs when used EPSs of
lactic acid bacteria [89, 116]. In general, many functional
groups have been mentioned to carry out the reduction
and stabilization of metal nanoparticles (Ag-NPs, Au-NPs,
and FeO-NPs) by bacterial EPS such as hydroxyl, carboxyl,
ester, aldehydes, methoxyl, sulfated, phosphate, amino,
amide, and N-acetylated sugar molecules that possess
negative charge and interact with metal ions by electrostatic
attractive forces, thereby producing metal nanoparticles as
described above [33, 87, 88, 90, 91, 103]. Thus, the above
information may explain the reduction process of metal
ions to form the respective nanoparticles, as well as their
mechanisms to the effective stabilization that bacterial EPSs
can carry out during the obtaining of metal nanoparticles.
A representation of the information in this section is shown
in Figure 3.
7. Main Techniques Used to Characterize Metal
Nanoparticles and Biomedical Measurements
7.1. Instrumental Techniques to Characterize Metal
Nanoparticles. After the production of metal nanoparticles
(in this study, by means of bacterial exopolysaccharides),
there are some characteristics that required their proper
characterization, such as shape, size, surface, and dispersity
[117]. These characterization can be achieved by various
instrumental techniques. In this context, ultraviolet-visible
spectroscopy (UV-visible spectroscopy) has been very useful
to rapidly detect the formation of different metal nanopar-
ticles (silver, copper, gold, and platinum nanoparticles)
since the surface plasmon resonance (SPR) phenomenon
can be measured [118]. For the case of shape, size, morphol-
ogy, and particle size distribution of metal nanoparticles,
transmission electron microscopy (TEM), high-resolution
electron microscopy (HRTEM), scanning electron micros-
copy, atomic force microscopy (AFM), and dynamic light
scattering are suitable techniques that have been used to
measure these physical properties of metal nanoparticles
[117, 119–124]. Crystallinity and the structure of metal
nanoparticles are other physical characteristics which can
be measured by X-ray diffraction and selected area electron
diffraction (SAED) technique [125, 126]. To identify and
confirm the elemental composition of metal nanoparticles
and their capping, energy-dispersive spectrometry (EDS) is
a proper technique for this purpose [127]. When metal
nanoparticles possess a capping or stabilizing agent,
Fourier-transform infrared spectroscopy (FTIR) is applied
to identify the functional groups present in the nanoparticle
surface, and Zeta potential is used to determine the surface
charge [128, 129]. In addition, when magnetic nanoparticles
are produced, vibrating sample magnetometry (VSM) and
superconducting quantum interference device (SQUID)
magnetometry are adequate techniques to measure magnetic
properties [130].
(1)
Metal salts
Exopolysaccharide
Functional groups
(2)
(a) Metal stabilization
(b) Metal reduction
(c) Nucleation
(3)
EPS- capped metal nanoparticle
Figure 3: Proposed mechanism during synthesis of metal nanoparticles by EPSs. Electrostatic attractive forces between functional
groups of EPS and metal salts lead to stabilization and reduction of metal ions to form their respective metal nanoparticles capped
by the EPSs.
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7.2. Biomedical Measurements Applied to Metal Nanoparticles
Synthesized by EPSs as a Reducing and/or Stabilizing Agents.
In relation to biomedical measurements carried out during
biomedical applications of metal nanoparticles synthesized
by bacterial EPSs, the antimicrobial activity of metal nanopar-
ticles synthesized by bacterial EPSs has been measured by
determination of minimum inhibitory concentration (MIC)
[85, 86, 102, 120], minimum bactericidal concentration
(MBC) [86, 120], fluorescence microscopy imaging (FMI)
[120], skin infection model in vivo by colony counting method
using the pour plate technique [120], agar disc diffusion
method [53, 70, 72, 90, 91], agar well diffusion method
[33, 85, 86, 88, 90–92, 102], colony counting method [76],
antibiofilm activity [85, 102], bacterial growth kinetics tests,
and kill time assays [85, 86, 92, 102]. Moreover, antifungal
activity was measured by agar well and disk diffusion method
[72, 102] as well as larvicidal activity using the World Health
Organization method [102, 131].
On the other hand, metal nanoparticles produced by EPS
as an anticancer agent and drug delivery carrier has been
tested by some of biomedical measurements such as in vitro
drug-released studies by dialysis method [69], in vivo studies
of biochemical parameters and histopathological assays of
liver and kidney functions and oxidation stress ratio [55],
in vitro cytotoxicity and anticancer assays against tumor cell
lines by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide) colorimetric method [75, 103, 132],
tumor cellular uptake by confocal laser scanning microscopy
[75, 77], internalization of metal nanoparticles in tumor cells
by cellular imaging and flow cytometry studies [59], cell
viability by in vitro cytotoxicity and biocompatibility tests
by alamar blue assay [59], antiproliferation of cancer cells
using magnetic hyperthermia method (MHM) and qualita-
tively determination of live and dead cells after MHM [59],
and measuring of tumor cell death by acridine orange/
ethidium bromide staining assay [103].
In this context, other biomedical measurements related
with other applications are cysteine detection by absorption
spectroscopy and visual inspection during color change
[71], biocompatibility assays by cytotoxicity studies using
MTT method [54, 95, 96], toxicological tests by measuring
in vivo studies of oral, dermal, and immunotoxicity, as well
as genotoxicity, carcinogenicity, biochemical and hematolog-
ical parameters, and histopathological analysis [96], interac-
tion with protein assay employing fluorescence, circular
dichroism spectroscopies and UV-visible spectroscopy
[60, 74], in vitro ROS scavenging assay and antioxidant
activities by DPPH (2,2-diphenyl-1-picrylhydrazyl), Trolox
and ferric-reducing ability of plasma (FRAP) tests [54, 57],
and in vitro MRI of cell phantoms to assess nanoprobes
for cell labeling by MRI [56]. Thus, there are many ways
to measure the potential of metal nanoparticles synthe-
sized by EPSs as a reducing and/or stabilizing agent in
different important biomedical applications today.
Ag
Au
Fe3O4
Cu
Pd
Se
Zn ZnOProduction and 
secretion of EPSs
Bacteria
Reduction/stabilization
Green approach
Metal
ions
EPS EPS
EPS
Metal
nanoparticles
Capping
Exopolysaccharides
(EPSs):
Biomedical applications:
Other applications:
remediation
(i) Xhantan gum
(ii) Dextran
(iii) Curdlan
(iv) Gellam gum
(v) Cellulose
(i) Antimicrobial
(ii) Anticancer
(i) Catalysis
(ii) Environmental
(iii) Antioxidant
(iv) Drug delivery
(v) Chemical sensor
(vi) Levan
(vii) Succinoglycan
(viii) FucoPol
(ix) GalactoPol
Figure 4: Summary of the content of this review.
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8. Conclusions
Metal nanoparticles have been an important research target
within the last decades, mainly because they have different
properties than when in the bulk. Metal nanoparticles have
been found to have beneficial properties for biomedical
applications such as antimicrobial, anticancer, antioxidant,
drug delivery, chemical sensors, contrast agents, and also in
other applications such as catalysts and environmental
remediation agents. Therefore, there is an interest in finding
different compounds capable of effectively reducing and
stabilizing metal nanoparticles. Green synthesis methods
have gotten a lot of attention in the production of metallic
nanoparticles, since these synthesis follow a process that
involves almost exclusively the metallic salt precursor and a
biological compound that performs either the chelation of
the reduced metal, its stabilization, or both functions at the
same time. Moreover, green synthesis methods have a wide
array of advantages when comparing them with physical
and chemical production methods; green synthesis provides
and environmental friendly and cost-effective synthesis
platform, employing nontoxic reagents and procedures.
Bacterial EPSs are biomolecules that possess attractive
properties to be exploited, in green synthesis production of
metallic nanoparticles, due to their chemical composition.
Bacterial EPS are heteropolysaccharides containing different
functional groups in their backbone including amino,
sulfate, phosphate, and hydroxyl substituents as well as
N-acetylamino sugars and hemiacetal ends; all of these
functional groups are great candidates in the reduction,
complexation, and stabilization of metal nanoparticles
during their synthesis. However, there are still several
challenges in the use of bacterial EPS to aid in the synthesis
of metallic nanoparticles, mainly the wide variability of the
EPS chemical composition. Depending on the composition
of the chosen EPS, the reaction conditions change, such as
the temperature, reaction time, concentration, and rate of
precursor salts to EPS. Furthermore, all of these synthesis
parameters have shown to have a direct influence on the
morphological characteristics of the produced nanoparticles.
Thus, bacterial EPSs are a suitable option to synthesize
different functionalized metal nanoparticles to be used in
biomedical and other types of applications. Using some
bacterial EPS allows the production of metal nanoparticles,
with a wide variety of applications, in an eco-friendly and
nontoxic manner, conferring interesting characteristics
through the functionalization of these nanomaterials. How-
ever, more research is needed related to the understanding
of mechanisms involved in the process of reduction and
stabilization during synthesis of metal nanoparticles, as well
as more thorough toxicological and environmental studies
to measure their impact on our society and the environ-
ment. Figure 4 illustrates a summary of the main content
of this review.
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